Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.44 |
| ▸ | ADH1B | P00325 | 1/20 | 0.43 |
| ▸ | ADH1C | P00326 | 1/20 | 0.43 |
| ▸ | ADH1A | P07327 | 1/20 | 0.43 |
| ▸ | ADH4 | P08319 | 1/20 | 0.43 |
| ▸ | ADH7 | P40394 | 1/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.37 |
| ▸ | FDPS | P14324 | 3/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11900455 | 1.00 | TSHR (0.44) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL5613606 | 1.00 | TSHR (0.44) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL1157220 | 1.00 | TSHR (0.44) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL5613440 | 1.00 | TSHR (0.44) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL1157731 | 1.00 | TSHR (0.44) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL11901187 | 1.00 | TSHR (0.44) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL10555437 | 1.00 | TSHR (0.44) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL5613218 | 1.00 | TSHR (0.44) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL5613613 | 1.00 | TSHR (0.44) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL5613158 | 1.00 | TSHR (0.44) | TSHROPRM1ADH1BADH1CADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250179232-A1 | RESIN COMPOSITION, MOLDED PRODUCT, AND OPTICAL MEMBER | ZEON CORPORATION (JP) | 2025-06-05 | — | — | US | disclosed |
| EP-4502076-A1 | RESIN COMPOSITION, MOLDED BODY, AND OPTICAL MEMBER | Zeon Corporation (JP) | 2025-02-05 | — | — | EP | disclosed |
| CN-118302490-A | Resin composition, molded body, and optical member | 日本瑞翁株式会社 | 2024-07-05 | — | — | CN | disclosed |
| CN-114716599-B | Olefin copolymer and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-02-13 | — | — | CN | disclosed |
| WO-2023189303-A1 | RESIN COMPOSITION, MOLDED BODY, AND OPTICAL MEMBER | 日本ゼオン株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023085299-A1 | CATIONIC LIPID | 武田薬品工業株式会社 | 2023-05-19 | — | — | WO | disclosed |
| CN-114716599-A | Olefin copolymer and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-07-08 | — | — | CN | disclosed |
| EP-2984055-B1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | MATERIA INC (US) | 2018-10-17 | — | — | EP | disclosed |
| US-9758445-B2 | Preparation of surfactants via cross-metathesis | MATERIA, INC. (US) | 2017-09-12 | — | — | US | disclosed |
| EP-2940055-B1 | OPTICAL POLYMER AND OPTICAL ELEMENT OBTAINED BY FORMING THEREOF | ZEON CORP (JP) | 2017-08-30 | — | — | EP | disclosed |
| US-9663459-B2 | Preparation of surfactants via cross-metathesis | MATERIA, INC. (US) | 2017-05-30 | — | — | US | disclosed |
| US-9459376-B2 | Optical polymer and optical element obtained by forming thereof | ZEON CORPORATION (JP) | 2016-10-04 | — | — | US | disclosed |
| US-20160186094-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | MATERIA, INC. | 2016-06-30 | — | — | US | disclosed |
| US-20160145204-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | MATERIA, INC. | 2016-05-26 | — | — | US | disclosed |
| EP-2984055-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | Materia, Inc. (US) | 2016-02-17 | — | — | EP | disclosed |
| US-20150346386-A1 | OPTICAL POLYMER AND OPTICAL ELEMENT OBTAINED BY FORMING THEREOF | ZEON CORPORATION (JP) | 2015-12-03 | — | — | US | disclosed |
| EP-2940055-A1 | OPTICAL POLYMER AND OPTICAL ELEMENT OBTAINED BY FORMING THEREOF | Zeon Corporation (JP) | 2015-11-04 | — | — | EP | disclosed |
| WO-2015126462-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | MATERIA, INC. (US) | 2015-08-27 | — | — | WO | disclosed |
| WO-2014169080-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | MATERIA, INC. (US) | 2014-10-16 | — | — | WO | disclosed |
| US-20070270521-A1 | Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070270521-A1 | Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer | CARM1, CPN1, CCNT1 | TSHR 4291/4885OPRM1 290/4885ADH1B 1621/4885 |
| US-20160186094-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | SMURF2, EPHX2, SMURF1 | TSHR 4332/4885OPRM1 4197/4885ADH1B 3031/4885 |
| US-20160145204-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | SMURF2, SMURF1, ABCB4 | TSHR 3892/4885OPRM1 4215/4885ADH1B 3612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.